Company intelligence / Profile preview

Tomocube

Daejeon, Daejeon Metropolitan City, South Koreatomocube.com ↗

Ownership: Private
Employees: ~56
Development stage: Other

Overview

Tomocube’s holotomography platforms are commercially available and widely used in academic and industry settings for high-resolution, label-free live cell imaging. The technology enables non-invasive observation of cellular dynamics and subcellular structures in real time. There are no clinical trial results as the company does not develop therapeutics but provides enabling technologies for life science research.

Therapeutic areas: Other
Modalities: DeviceNon-pharmacological therapy (for research/diagnostic use)AI-powered imaging platform
Industry: Pathology

Partnerships

Not explicitly listed; likely collaborations with academic institutions and biotech/pharma researchers using their platforms.

Beyond the preview

Go deeper on Tomocube.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tomocube.

Explore the full profile